neurologic symptoms

临床试验

计划入组 30 人 · 首次发布于 2009 年 7 月 31 日

已完成

NCT04889313

Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC)

计划入组 50 人 · 首次发布于 2021 年 5 月 17 日

招募中

NCT05740683

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

计划入组 100 人 · 首次发布于 2023 年 2 月 23 日

药物

查看全部 154 →

BAY-55-8800

Small Molecule

Approved

Fenfluramine(Fintepla)

相关疾病：Seizures, Dravet Syndrome，另有 1 项

C₁₂H₁₆F₃N · Rx

Small Molecule

Approved

Dexbrompheniramine(Ala-hist Ir, Ala-hist PE, Dologen, Dologesic Reformulated Jun 2016)

生产企业：Schering corp sub schering plough corp

相关疾病：Allergic Rhinitis (AR), Upper respiratory tract hypersensitivity reaction, site unspecified

C₁₆H₁₉BrN₂

机构

查看全部 26 →

Center For Neurologic Study

United States

TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION

United States

Unity Biotechnology

United States

资讯

查看全部 5490 →

9个月前

Quadriga BioSciences Reports Promising Phase IIa Results for QBS72S in Breast Cancer Leptomeningeal Disease

6个月前

Triplet Therapy Doubles Survival in HER2-Positive Breast Cancer Patients with Leptomeningeal Metastasis

去年

临床试验

Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia

Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC)

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

药物

BAY-55-8800

Fenfluramine(Fintepla)

Dexbrompheniramine(Ala-hist Ir, Ala-hist PE, Dologen, Dologesic Reformulated Jun 2016)

机构

Center For Neurologic Study

TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION

Unity Biotechnology

资讯

Quadriga BioSciences Reports Promising Phase IIa Results for QBS72S in Breast Cancer Leptomeningeal Disease

Triplet Therapy Doubles Survival in HER2-Positive Breast Cancer Patients with Leptomeningeal Metastasis

Water Bead Injuries in Children Show Alarming Rise: National Study Reports 9% Requiring Escalated Care